Search research articles
Contact Us
Filters
Showing results (31-40 of 38) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 38 results.
Cancers
|
December 2, 2020
Combined CDK2 and CDK4/6 Inhibition Overcomes Palbociclib Resistance in Breast Cancer by Enhancing Senescence
Kamal Pandey, Nahee Park, Kyung-Soon Park, et al.
Scientific Reports
|
January 22, 2020
Immune gene signatures for predicting durable clinical benefit of anti-PD-1 immunotherapy in patients with non-small cell lung cancer
Sohyun Hwang, Ah-Young Kwon, Ju-Yeon Jeong, et al.
The Journal of Clinical Investigation
|
July 26, 2019
STING activation reprograms tumor vasculatures and synergizes with VEGFR2 blockade
Hannah Yang, Won Suk Lee, So Jung Kong, et al.
Journal for Immunotherapy of Cancer
|
October 21, 2021
High endothelial venule is a surrogate biomarker for T-cell inflamed tumor microenvironment and prognosis in gastric cancer
Hyung Soon Park, Yoo Min Kim, Sewha Kim, et al.
Cancer Research and Treatment
|
February 6, 2020
Clinical Impact of Somatic Variants in Homologous Recombination Repair-Related Genes in Ovarian High-Grade Serous Carcinoma
Min Chul Choi, Sohyun Hwang, Sewha Kim, et al.
Journal of Cancer
|
June 18, 2019
Serum exosomal miRNA-145 and miRNA-200c as promising biomarkers for preoperative diagnosis of ovarian carcinomas
Sewha Kim, Min Chul Choi, Ju-Yeon Jeong, et al.
Oncotarget
|
February 9, 2018
CD44/CD24 and aldehyde dehydrogenase 1 in estrogen receptor-positive early breast cancer treated with tamoxifen: CD24 positivity is a poor prognosticator
Yong Wha Moon, Hee-Jung An, Ja Seung Koo, et al.
Cancers
|
August 27, 2021
<i>USP19</i> and <i>RPL23</i> as Candidate Prognostic Markers for Advanced-Stage High-Grade Serous Ovarian Carcinoma
Haeyoun Kang, Min Chul Choi, Sewha Kim, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 38) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 38 results.
Cancers
|
December 2, 2020
Combined CDK2 and CDK4/6 Inhibition Overcomes Palbociclib Resistance in Breast Cancer by Enhancing Senescence
Kamal Pandey, Nahee Park, Kyung-Soon Park, et al.
Scientific Reports
|
January 22, 2020
Immune gene signatures for predicting durable clinical benefit of anti-PD-1 immunotherapy in patients with non-small cell lung cancer
Sohyun Hwang, Ah-Young Kwon, Ju-Yeon Jeong, et al.
The Journal of Clinical Investigation
|
July 26, 2019
STING activation reprograms tumor vasculatures and synergizes with VEGFR2 blockade
Hannah Yang, Won Suk Lee, So Jung Kong, et al.
Journal for Immunotherapy of Cancer
|
October 21, 2021
High endothelial venule is a surrogate biomarker for T-cell inflamed tumor microenvironment and prognosis in gastric cancer
Hyung Soon Park, Yoo Min Kim, Sewha Kim, et al.
Cancer Research and Treatment
|
February 6, 2020
Clinical Impact of Somatic Variants in Homologous Recombination Repair-Related Genes in Ovarian High-Grade Serous Carcinoma
Min Chul Choi, Sohyun Hwang, Sewha Kim, et al.
Journal of Cancer
|
June 18, 2019
Serum exosomal miRNA-145 and miRNA-200c as promising biomarkers for preoperative diagnosis of ovarian carcinomas
Sewha Kim, Min Chul Choi, Ju-Yeon Jeong, et al.
Oncotarget
|
February 9, 2018
CD44/CD24 and aldehyde dehydrogenase 1 in estrogen receptor-positive early breast cancer treated with tamoxifen: CD24 positivity is a poor prognosticator
Yong Wha Moon, Hee-Jung An, Ja Seung Koo, et al.
Cancers
|
August 27, 2021
<i>USP19</i> and <i>RPL23</i> as Candidate Prognostic Markers for Advanced-Stage High-Grade Serous Ovarian Carcinoma
Haeyoun Kang, Min Chul Choi, Sewha Kim, et al.
Page
of 4